Intellicyt Announces Record 2015 Sales
January 25, 2016
Albuquerque, New Mexico – January 25, 2016 Business Wire – Intellicyt, a leading provider of integrated platforms that accelerate drug discovery, antibody screening and immuno-oncology research, today announced record sales results for 2015. The successful launch of the iQue® Screener PLUS system as well as increased sales of the company’s other instrumentation, software and reagent products resulted in sales growth of 68 percent for the year.
Intellicyt’s solutions enable the study of cells and cellular processes in pharmaceutical and translational research. The company’s iQue Screener platform is an integrated instrument, software and reagent system that enables rapid, high-content, multiplexed analysis of cell- and bead-based samples in liquid suspension. It minimizes volume requirements of precious samples and costly reagents, delivering analysis in 96-, 384- or 1536-well microplates at unprecedented speeds. The system’s data analysis and visualization software provides unique insights into the complex biology of disease. This ability to better understand the biological mechanisms of disease early in the drug discovery process lowers costs, reduces attrition rates and will ultimately result in better, safer more efficacious drugs. Intellicyt’s products are used in laboratories at the top 15 pharmaceutical companies, leading biotechnology companies and premier medical centers around the world.
“We successfully implemented an aggressive commercialization strategy with the $7.4 million of growth capital that we raised last year,” said R. Terry Dunlay, president and CEO of Intellicyt. “We are very pleased with the demand for our products in a range of drug discovery applications and the strong demand from the immuno-oncology market in particular. We now have over 300 instrumentation systems in service in 18 countries worldwide.”
About Intellicyt
Intellicyt manufactures and sells instrumentation, software and reagents that facilitate the study of cells and their components to gain a better understanding of normal and disease processes. This information speeds the discovery and development of new drugs and provides new insight for the diagnosis of diseases. Intellicyt’s products are used worldwide throughout the pharmaceutical and biotechnology industries and in nonprofit research labs. For more information, please visit www.intellicyt.com.
Media Contact
Click here to contact Intellicyt.